Checkpoint Therapeutics Announces Exercise of Warrants for $11.13 Million in Gross Proceeds Oct 02, 2023
Checkpoint Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference Sep 06, 2023
Journey Medical Corporation Enters into an Exclusive License Agreement with Maruho Co., Ltd. for Qbrexza® in South Korea and Other Asian Nations Sep 06, 2023
Avenue Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference Sep 05, 2023
Mustang Bio Announces First Data from Ongoing Multicenter Phase 1/2 Clinical Trial Evaluating MB-106 CAR-T Cell Therapy Aug 16, 2023
Checkpoint Therapeutics Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights Aug 14, 2023
Mustang Bio Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights Aug 14, 2023
